Cost matters
- PMID: 24785839
- DOI: 10.1097/AOG.0000000000000257
Cost matters
Comment on
-
Carboxymethylcellulose adhesion barrier placement at primary cesarean delivery and outcomes at repeat cesarean delivery.Obstet Gynecol. 2014 May;123(5):923-928. doi: 10.1097/AOG.0000000000000220. Obstet Gynecol. 2014. PMID: 24785841
-
Cost-effectiveness of testing hepatitis B-positive pregnant women for hepatitis B e antigen or viral load.Obstet Gynecol. 2014 May;123(5):929-937. doi: 10.1097/AOG.0000000000000124. Obstet Gynecol. 2014. PMID: 24785842 Free PMC article.
-
Cost-benefit analysis of indirect antiglobulin screening in Rh(D)-negative women at 28 weeks of gestation.Obstet Gynecol. 2014 May;123(5):938-945. doi: 10.1097/AOG.0000000000000224. Obstet Gynecol. 2014. PMID: 24785843
Similar articles
-
Cost-benefit analysis of indirect antiglobulin screening in Rh(D)-negative women at 28 weeks of gestation.Obstet Gynecol. 2014 May;123(5):938-945. doi: 10.1097/AOG.0000000000000224. Obstet Gynecol. 2014. PMID: 24785843
-
The prevention of Rh immunization.Transfus Med Rev. 1988 Sep;2(3):129-50. doi: 10.1016/s0887-7963(88)70039-5. Transfus Med Rev. 1988. PMID: 2856526 Review. No abstract available.
-
[Social Welfare Board's recommendations for preventive treatment in the origin of Rh immunization].Jordemodern. 1987 Oct;100(10):321-4. Jordemodern. 1987. PMID: 2826372 Swedish. No abstract available.
-
Antenatal Rh immunoglobulin--help or hindrance?Transfusion. 1985 Jan-Feb;25(1):88. doi: 10.1046/j.1537-2995.1985.25185116521.x. Transfusion. 1985. PMID: 2982225 No abstract available.
-
Economics of antenatal prophylaxis.Br J Obstet Gynaecol. 1998 Nov;105 Suppl 18:19-22. doi: 10.1111/j.1471-0528.1998.tb10287.x. Br J Obstet Gynaecol. 1998. PMID: 9863974 Review. No abstract available.
References
-
- Edwards RK, Ingersoll M, Gerkin RD, Bodea-Braescu AV, Lin MG. Carboxymethylcellulose adhesion barrier placement at primary cesarean delivery and outcomes at repeat cesarean delivery. Obstet Gynecol 2014;123:923–8.
-
- Fan L, Owusu-Edusei K, Schillie SF, Murphy TV. Cost-effectiveness of testing hepatitis b–positive pregnant women for hepatitis b e antigen or viral load. Obstet Gynecol 2014;123:929–37.
-
- Salemi JL, Comins MM, Chandler K, Mogos MF, Salihu HM. A practical approach for calculating reliable cost estimates from observational data: application to cost analyses in maternal and child health. Appl Health Econ Health Policy 2013;11:343–57.
-
- Abbey R, Dunsmoor-Su R. Cost-benefit analysis of indirect antiglobulin screening in rh(d)-negative women at 28 weeks of gestation. Obstet Gynecol 2014;123:938–45.
-
- Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC. The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. JAMA 1996;276:1172–7.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical